Human bone marrow mesenchymal cells express NG2: Possible increase in discriminative ability of flow cytometry during mesenchymal stromal cell identification

Cytotherapy

Volumn 11, Issue 5, 2009, Pages 527-533

  Kozanoglu, Ilknur ^a   Boga, Can ^a   Ozdogu, Hakan ^a   Sozer, Oktay ^a   Maytalman, Erkan ^a   Yazici, Ayse Canan ^a   Sahin, Feride Iffet ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Flow cytometry; Human bone marrow; Mesenchymal stromal cells; NG2

Indexed keywords

5' NUCLEOTIDASE; ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; CELL ANTIGEN; ENDOGLIN; NEURAL GLIAL ANTIGEN NG2; UNCLASSIFIED DRUG;

ADIPOGENESIS; ADULT; ANTIGEN EXPRESSION; ARTICLE; BONE DEVELOPMENT; CELL CULTURE; CELL DIFFERENTIATION; CELL ISOLATION; CELL VIABILITY; CHROMOSOME ANALYSIS; DISCRIMINANT ANALYSIS; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MALE; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; STROMA CELL;

ADIPOGENESIS; ADULT; ANTIGENS; ANTIGENS, CD; BONE MARROW CELLS; CELL SEPARATION; CELL SHAPE; CELLS, CULTURED; FEMALE; FLOW CYTOMETRY; HUMANS; KARYOTYPING; MALE; MESENCHYMAL STEM CELLS; OSTEOGENESIS; PROTEOGLYCANS; RECEPTORS, CELL SURFACE; STROMAL CELLS;

EID: 70849104234     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1080/14653240902923153     Document Type: Article

References (21)

1. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147
2. Jiang Y , Jahagirdar BN , Reinhardt RL , Schwartz RE, Keene CD , Ortiz-Gonzalez XR , et al . Pluripotency of mesenchymal stem cells derived from adult marrow . Nature 2002 ; 418 : 41-9 . Erratum in Nature 2007 ; 447 : 879-880
3. Majumdar MK, T hiede MA, Haynesworth SE, Bruder SP, Gerson SL. Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages. J Hematother Stem Cell Res 2000; 9: 841-848
4. Koc ON, G erson SL, C ooper BW, D yhouse SM, Haynesworth SE, Caplan AI, Lazarus HM. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 2000; 18: 307-316
5. Le Blanc K, T ammik C, Rosendahl K, Zetterberg E, Ringden O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 2003; 31: 890-896
6. Le Blanc K, T ammik L, Sundberg B, Haynesworth SE, Ringden O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 2003; 57: 11-20.
7. Le Blanc K, R asmusson I, Sundberg B, Gotherstrom C, Hassan M, Uzunel M, Ringden O. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004; 363: 1439-1441
8. Maitra B, S zekely E, Gjini K, L aughlin MJ, Dennis J, Haynesworth SE, Koc ON. Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant 2004; 33: 597-604.
9. Horwitz EM, G ordon PL, K oo WK, M arx JC, N eel MD, McNall RY, et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci USA 2002; 99: 8932-8937
10. Friedenstein AJ, Latzinik NW, G rosheva AG, G orskaya UF. Marrow microenvironment transfer by heterotopic transplantation of freshly isolated and cultured cells in porous sponges. Exp Hematol 1982; 10: 217-227
11. Wexler SA, D onaldson C, D enning-Kendall P, R ice C, B radley B, Hows JM. Adult bone marrow is a rich source of human mesenchymal 'stem' cells but umbilical cord and mobilized adult blood are not. Br J Haematol 2003; 121: 368-374
12. Stute N, H oltz K, B ubenheim M, L ange C, B lake F, Z ander AR. Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use. Exp Hematol 2004; 32: 1212-1225
13. Bobis S, Jarocha D, Majka M. M esenchymal stem cells: Characteristics and clinical applications. Folia Histochem Cytobiol 2006; 44: 215-230
14. Jones EA, E nglish A, K insey SE, Straszynski L, Emery P, Ponchel F, McGonagle D. Optimization of a fl ow cytometry-based protocol for detection and phenotypic characterization of multipotent mesenchymal stromal cells from human bone marrow. Cytometry B Clin Cytom 2006; 70: 391-399
15. Stallcup WB. T he NG2 proteoglycan: Past insights and future prospects. J Neurocytol 2002; 31: 423-435
16. Neudenberger J, Hotfi lder M, Rosemann A, L angebrake C, Reinhardt D, Pieters R, et al. Lack of expression of the chondroitin sulphate proteoglycan neuron-glial antigen 2 on candidate stem cell populations in paediatric acute myeloid leukaemia/abn(11q23) and acute lymphoblastic leukaemia/t(4;11). Br J Haematol 2006; 133: 337-344
17. Caplan AI. M esenchymal stem cells. J Orthop Res 1 991; 9: 641-650
18. Verma RS, Babu A. Human Chromosomes Principles and Techniques, 2nd edn. New York: McGraw Hill Inc., 1994; 6-71.
19. Ozerdem U, Grako KA, Dahlin-Huppe K, M onosov E, Stallcup WB. NG2 proteoglycan is expressed exclusively by mural cells during vascular morphogenesis. Dev Dyn 2001; 222: 218-227
20. Aerts F, Wagemaker G. M esencyhmal stem cell engineering and transplantation . In Genetic Engineering of Mesenchymal Stem Cells , 1st edn. Nolta JA, ed . Netherlands : Springer , 2006 ; 1-44.
21. Martinez C , Hofmann TJ , M arino R , Dominici M , Horwitz EM. Human bone marrow mesenchymal stromal cells express the neural ganglioside GD2: A novel surface marker for the identifi cation of MSCs . Blood 2007 ; 109 : 4245-8 . Erratum in Blood 2007 ; 110-826.